4//SEC Filing
Guenther Sven 4
Accession 0001437749-22-002400
CIK 0001434647other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 5:17 PM ET
Size
5.6 KB
Accession
0001437749-22-002400
Insider Transaction Report
Form 4
KEMPHARM, INCKMPH
Guenther Sven
Exec VP R&D
Transactions
- Award
Stock Option (right to buy)
2022-02-01+83,486→ 83,486 totalExercise: $7.17Exp: 2032-01-31→ Common Stock (83,486 underlying)
Footnotes (1)
- [F1]Grant to the Reporting Person of a stock option under the Issuer's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). 25% of the shares will vest on February 1, 2023 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant.
Documents
Issuer
KEMPHARM, INC
CIK 0001434647
Entity typeother
Related Parties
1- filerCIK 0001638368
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 5:17 PM ET
- Size
- 5.6 KB